This award recognises Cell Signaling Technology as the company with the most antibody citations during 2017 based on data from CiteAb.
From the data generated through CiteAb, we are able to gain a really clear picture of the way antibodies are used around the world. We can tell which countries are investing most in research using antibodies, which companies are seeing growth or decline, which antibodies are most successful and which areas of research are seeing growth.
Dr Andrew Chalmers, Founder of CiteAb, said: “This is an esteemed award which recognises Cell Signaling Technology as the most successful antibody company based on our data from CiteAb. This is no mean feat which would not have happened without the company offering a large number of products that help researchers make novel findings, and without a huge amount of effort from everybody at Cell Signaling Technology. We wholeheartedly congratulate you all on your achievement.”
Explore additional categories featuring in the 2018 CiteAb Awards.
Highlighting an outstanding individual who has made a significant impact in the reagent sector.
Shedding light on the reagent supplier that researchers have been most impressed by in 2017.
Recognising the most exciting new antibody validation initiative in the sector from 2017.
Celebrating reagents or instruments that are set to change the sector.
Rewarding the company with the most antibody citations during 2017.
An exciting award for the company with the largest percentage increase in citations during 2017.
A new category recognising the chemical probes supplier with the most citations during 2017.
A new category, recognising the chemical probes company with the largest percentage increase in citations in 2017.
Awarding the company that has secured the most custom antibody citations over the past 3 years.
An award to recognise the company with the most citations achieved in the cancer biology market during 2017.
This award recognises the antibody company which has achieved the largest increase in antibody market share over the past five years.
Recognising the most cited flow cytometer instrument during 2017.